EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using Manganese‐Enhanced DCE ‐ MRI to Assess Blood‐Cerebrospinal Fluid Barrier Transport

Charith Perera iD, Zhiping Feng iD, Shereen Nizari iD, Phillip Muza iD, Christina Katsiva iD, Tammy L Kalber iD, Mark F Lythgoe iD, Ian F Harrison iD, Daniel J Stuckey iD, Jack A Wells iD

Magnetic Resonance in Medicine · 2026

DOI: 10.1002/mrm.70531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2026. Verfasst von Charith Perera und 9 weiteren Autor:innen. Beteiligte Einrichtung: UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK. Hauptthemen laut MEDLINE: Dynamic Contrast Enhanced Magnetic Resonance Imaging, Manganese, Blood-Brain Barrier, Cerebrospinal Fluid. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Brain Tumour Charity, Rosetrees Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We developed a dynamic, heavily T2‐weighted (hT2w) FLAIR protocol to resolve acute Mn 2+ transport kinetics, as a proxy for Ca 2+ , across the choroid plexus (ChP)—cerebrospinal fluid (CSF) interface, in vivo. By quantifying intercompartmental Mn 2+ dynamics, and comparing these with Gd‐DOTA, we sought to characterize blood‐CSF‐barrier (BCSFB)‐mediated tracer transport, combining high in‐plane resolution and 4‐min temporal sampling. Methods hT2w‐FLAIR DCE MRI was conducted in anesthetized C57BL/6 mice, receiving intravenous Mn 2+ or Gd‐DOTA. Semi‐quantitative tracer kinetic modeling permitted regional and inter‐tracer comparisons.

Results

Mn 2+ rapidly crossed from the vasculature into the CSF, across the ChP, with similar arrival times and time‐to‐peak across compartments. Mn 2+ delivery into the ChP exhibited a 5.7‐fold steeper uptake rate ( p = 0.031) and a 5.6‐fold higher peak signal amplitude ( p = 0.0028) than in the LV‐CSF. In contrast, Gd‐DOTA exhibited a 2.2‐fold shorter ChP plateau duration ( p = 0.034) and 2.2‐fold faster ChP clearance rate ( p = 0.0047), compared to Mn 2+ . Within the CSF, there were significant temporal delays with Gd‐DOTA relative to Mn 2+ : a lengthened arrival (eight‐fold, p = 0.045) and time‐to‐peak (six‐fold, p = 0.024).

Conclusion

Our hT2w‐FLAIR DCE‐MRI approach captured the early BCSFB transport window for Mn 2+ , providing distinct ChP and LV‐CSF kinetics at a higher temporal resolution and with reduced CSF signal contamination compared to prior approaches. These findings highlight that MRI tracer choice strongly shapes measured BCSFB kinetics, and supports the use of Mn 2+ as a tool for probing compartment‐specific ChP transport.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dynamic Contrast Enhanced Magnetic Resonance ImagingManganeseBlood-Brain BarrierCerebrospinal FluidMagnetic Resonance ImagingAnimalsMice, Inbred C57BLMiceContrast MediaHeterocyclic CompoundsOrganometallic CompoundsChoroid PlexusMale

Stichwörter der Autor:innen

blood cerebrospinal fluid barrier (BCSFB)braincerebrospinal fluid (CSF)choroid plexus (ChP)fluid‐attenuated inversion recovery (FLAIR)gadolinium‐based contrast agents (GBCA)high field (9.4 T)manganese‐enhanced MRI (MEMRI)mousepreclinical

Substanzen

ManganeseContrast MediaHeterocyclic CompoundsOrganometallic Compoundsgadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate

Autor:innen und Institutionen

  • UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.

ORCID-Profile: Charith Perera, Zhiping Feng, Shereen Nizari, Phillip Muza, Christina Katsiva, Tammy L Kalber, Mark F Lythgoe, Ian F Harrison, Daniel J Stuckey, Jack A Wells

Förderung

  • Wellcome Trust
  • Brain Tumour Charity
  • Rosetrees Trust
  • British Heart Foundation
  • Cancer Research UK
  • Parkinson's UK
  • UCL Birkbeck MRC DTP
  • Medical Research Council

Zitieren

APA

Perera, C., Feng, Z., Nizari, S., Muza, P., Katsiva, C., Kalber, T. L., Lythgoe, M. F., Harrison, I. F., Stuckey, D. J., & Wells, J. A. (2026). Using Manganese‐Enhanced DCE ‐ MRI to Assess Blood‐Cerebrospinal Fluid Barrier Transport. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.70531

Vancouver

Perera C, Feng Z, Nizari S, Muza P, Katsiva C, Kalber TL, et al. Using Manganese‐Enhanced DCE ‐ MRI to Assess Blood‐Cerebrospinal Fluid Barrier Transport. Magnetic Resonance in Medicine. 2026. doi:10.1002/mrm.70531

BibTeX
@article{Perera2026,
  author = {Perera, Charith and Feng, Zhiping and Nizari, Shereen and Muza, Phillip and Katsiva, Christina and Kalber, Tammy L and Lythgoe, Mark F and Harrison, Ian F and Stuckey, Daniel J and Wells, Jack A},
  title = {Using Manganese‐Enhanced DCE ‐ MRI to Assess Blood‐Cerebrospinal Fluid Barrier Transport},
  journal = {Magnetic Resonance in Medicine},
  year = {2026},
  doi = {10.1002/mrm.70531}
}
Kostenlos starten →